Psychedelics ‘show some promise’ for select patients, TGA told
An independent panel has reviewed the literature on MDMA and psilocybin
The psychedelic substances psilocybin and MDMA (ecstasy) hold some potential for treating mental illness in a select group of patients, an expert panel suggests.
However, in a report to the TGA, the group stressed their findings only applied to the drugs being administered under close clinical supervision with intensive support.
